Sees FY23 adjusted EBITDA $($50M)-($48M).
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on SNCE:
- Science 37 Reports Fourth Quarter and Full Year 2022 Financial Results
- Science 37 to Present at the Cowen 43rd Annual Health Care Conference
- Science 37 to Report Fourth Quarter 2022 Financial Results on March 6, 2023
- Science 37 Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
- Science 37 Acquires Vault Health’s Life Sciences Platform To Bolster its Metasite Capabilities